WFC
WST icon

Western Financial Corp’s West Pharmaceutical WST Stock Holding History

Western Financial Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,710
Closed -$1.52M – 109
2022
Q1 		$1.52M Buy
3,710
+232
+7% +$90.8K 0.88% 21
2021
Q4 		$1.63M Buy
3,478
+550
+19% +$237K 0.86% 20
2021
Q3 		$1.24M Sell
2,928
-549
-16% -$231K 0.74% 24
2021
Q2 		$1.25M Buy
3,477
+96
+3% +$31.7K 0.67% 22
2021
Q1 		$953K Buy
3,381
+501
+17% +$143K 0.58% 30
2020
Q4 		$815K Buy
+2,880
New +$808K 0.54% 29

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Western Financial Corp's WST Position: Q2 2022 in Review

Western Financial Corp sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 3,710 shares — an estimated $1.52M sold.

Western Financial Corp first reported a position in WST in Q4 2020 and held it in 6 quarters. The position peaked at $1.63M in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Western Financial Corp reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Western Financial Corp sold 3,710 West Pharmaceutical shares in Q2 2022, an estimated $1.52M.
  • Western Financial Corp first reported a position in West Pharmaceutical in Q4 2020 and held it in 6 quarters.
  • Western Financial Corp's West Pharmaceutical position peaked at $1.63M in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Western Financial Corp's 13F filing for Q2 2022, filed 22 Jul 2022.